Have you realized that something changed? From 2020, each product group in the Geistlich product line will be packaged in its own specially color-coded box, making it easier for you to find what you’re looking for.

Per million inhabitants: 70 doctors. A rate that is 78 times lower than the comparable figure in Switzerland. These are the facts; they outline the need in Senegal with its almost 15 million inhabitants. With its donation Geistlich wants to contribute to improving this situation.

Tina spending a day immersed in the role of a computer scientist – Timo wanting to know what it’s like to be a lab technician. These were the kinds of insights Geistlich Pharma was able to provide during Switzerland’s “National Future Day” on 14 November.

Success for Geistlich at the Sino-Swiss Business Awards held every two years. In the category of the “Nestlé award for outstanding achievements of an SME”, the family company from Central Switzerland won the top award and considerable recognition for the successful development of its business in China.

Geistlich Pharma has had its own presence in Japan since June 2019. In addition to expert advice on regeneration, Geistlich Pharma's activities focus on high-quality educational opportunities. At the end of September, partners and customers toasted a new era with Geistlich in Fukuoka/JP.

Not only does the Geistlich Pharma company have a history that goes back to 1851, it can also tell the history of its bone expertise. This is shown in the new movie, “The Best Kept Secret”.

Osteo Science Foundation was founded in 2013 by Dr. Peter Geistlich and Geistlich Pharma to advance hard and soft tissue regeneration in Oral and CranioMaxillofacial Surgery in North America. The foundation is now expanding to include global programming, extending programs and activities to serve Oral and CranioMaxillofacial Surgeons around the world.

Geistlich Pharma – a pioneer of regenerative dentistry – has successfully established ten of its twelve global subsidiaries in the past 16 years. Its dynamic development in the international markets has led to the construction of a new production building at its headquarters in Wolhusen. On August 30, the result of this investment amounting to the tens of millions was inaugurated in the presence of numerous guests.

Imagine if osteoarthritis of the knee, which so many people suffer from following partial meniscal resection, could be successfully combated? Geistlich Pharma is taking on the challenge of finding innovative ways to do this in cooperation with eleven other partners.

Geistlich Pharma is launching its own organization in Japan in early June. Aside from selling through the webshop and conventional channels, Geistlich is focusing on its longstanding commitment to education and training.